Michele Woodley, MD, one of the surgery center partners and a gastroenterology specialist, confirmed the new deal and said Symbion will now own 60 percent of the center. Symbion executives also discussed the acquisition in a second-quarter earnings call.
Dr. Woodley said the day-to-day operations of the center will remain the same.
